Valentina Favoni

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Epimutations in migraine and in medication overuse headache: a longitudinal study after acute medication withdrawal.

Epimutations in migraine and in medication overuse headache: a longitudinal study after acute medication withdrawal.

Journal: The journal of headache and pain

Published: January 27, 2026

DNA methylation signatures of treatment response in medication-overuse headache.

DNA methylation signatures of treatment response in medication-overuse headache.

Journal: The journal of headache and pain

Published: January 26, 2026

Whole blood DNA methylation signature of epigenetic aging in medication overuse headache.

Whole blood DNA methylation signature of epigenetic aging in medication overuse headache.

Journal: The journal of headache and pain

Published: January 26, 2026

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).

Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).

Journal: The journal of headache and pain

Published: July 28, 2025

Evidence-based guidelines for the pharmacological treatment of migraine.

Evidence-based guidelines for the pharmacological treatment of migraine.

Journal: Cephalalgia : an international journal of headache

Published: April 25, 2025

Evidence-based guidelines for the pharmacological treatment of migraine, summary version.

Evidence-based guidelines for the pharmacological treatment of migraine, summary version.

Journal: Cephalalgia : an international journal of headache

Published: April 25, 2025

Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure: The need for a broader perspective.

Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure: The need for a broader perspective.

Journal: Cephalalgia : an international journal of headache

Published: April 03, 2025

Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Journal: Journal of neurology

Published: April 02, 2024

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study.

Journal: European journal of neurology

Published: March 06, 2024

Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study.

Blood pressure monitoring in elderly migraineurs starting an anti-CGRP monoclonal antibody: a real-world prospective study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 29, 2024

Is physiotherapy in migraines known to sufferers? A cross-sectional study.

Is physiotherapy in migraines known to sufferers? A cross-sectional study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 24, 2023

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.

Journal: Journal of neurology

Published: October 03, 2023

Showing 1-12 of 65

Last Updated: 09/26/2026